Tevogen Bio Holdings Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue00000000
Cost of Goods Sold59K86K000104K102K100K
Gross Profit-59K-86K000-104K-102K-100K
R&D Expenses3.1M2.1M3.1M2.7M3.2M2.8M3.3M4.1M
Operating Expenses5.3M4.5M5.7M5.4M10.4M9.3M6.0M8.5M
Operating Income-5.4M-4.6M-5.7M-5.4M-10.4M-9.4M-6.1M-8.6M
Other Income / Gains-45K-67K3K-59K-11K-81K201K-1.1M
Net Income-5.4M-4.7M-5.7M-5.5M-10.4M-9.2M-5.9M-6.1M
EPS (Diluted)-1.61-1.20-1.50-1.53-3.255-2.60-1.735-1.97
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio00000000
General And Administrative Expenses2.3M2.5M2.6M2.7M7.2M000
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses2.3M2.5M2.6M2.7M7.2M6.4M2.7M4.4M
Other Expenses-59K-86K000000
Cost And Expenses5.4M4.6M5.7M5.4M10.4M9.4M6.1M8.6M
Interest Income00000006.00
Interest Expense-71K71K62K38K25K16K12K0
Depreciation And Amortization59K86K291K27K105K104K102K100K
Ebitda-5.5M-4.5M-5.4M-5.5M-10.2M-9.3M-5.8M-9.6M
Ebitdaratio00000000
Operating Income Ratio00000000
Income Before Tax-5.4M-4.7M-5.7M-5.5M-10.4M-9.4M-5.9M-9.7M
Income Before Tax Ratio00000000
Income Tax Expense00000000
Net Income Ratio00000000
Epsdiluted-1.61-1.20-1.50-1.53-3.255-2.60-1.735-1.97
Weighted Average Shs Out3.5M3.3M3.9M3.7M3.2M3.6M3.4M3.1M
Weighted Average Shs Out Dil3.5M3.3M3.9M3.7M3.2M3.6M3.4M3.1M